10.2 Communicating benefits, limits, and safety boundaries Within the current evidence and regulatory framework, GLP-1RA management should be proceduralized using explicit entry points, target goals, and exit rules to minimize uncertainty and risk spillover: The triple-question pre-prescription assessment: before prescribing, clinicians should systematically address three questions: (i) What is the patients metabolic risk tier (BMI/IR, MASLD, glycemic status, etc.)
& Knudsen, L
(2020) showed that the combination of metformin and pioglitazone induced significant reductions in the level of oncogenic genes (AKT3, DEPTOR, EIF4E, ILK, MTOR, PIK3C, and PRKCA) in TC cells
Something as simple as hydration and quitting smoking are low hanging fruit